封面
市场调查报告书
商品编码
1890931

实验室晶片市场按产品/服务、技术、应用、最终用户和地区划分

Lab on Chip Market, By Product and Service, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计到 2025 年,实验室晶片市场价值将达到 72.1 亿美元,到 2032 年将达到 138.7 亿美元,2025 年至 2032 年的复合年增长率为 9.8%。

报告内容 报告详情
基准年: 2024 2025年市场规模: 72.1亿美元
历史数据时期: 2020年至2024年 预测期: 2025年至2032年
预测期(2025-2032年)复合年增长率: 9.80% 预计2032年价值: 138.7亿美元

全球实验室晶片市场代表着微流体、生物技术和分析化学的创新融合,从根本上改变了医疗、製药和生命科学领域的诊断和调查方法。

实验室晶片(LOC)技术,也称为微流体装置,将多种实验室功能整合到尺寸仅为几毫米到几厘米的单一晶片上,从而以前所未有的精度和效率实现生物样品分析的微型化。这些先进的装置利用微通道、帮浦、混合器和检测器,在可控制的微环境中执行复杂的生化过程,包括样品製备、反应、分离和检测。

凭藉样本量少、试剂消费量低、分析时间短、通量高等特点,这项技术已成为现代即时诊断和个人化医疗的基础技术。随着全球医疗系统日益重视快速、准确且经济高效的诊断解决方案,尤其是在新冠疫情凸显分散式检查能力重要性的背景下,实验室晶片平台已成为下一代医疗设备的关键基础技术,支援从感染疾病检测、癌症生物标记分析到环境监测和药物研发等广泛应用。

市场动态

全球实验室晶片市场由多个强劲驱动因素推动,这些因素凸显了其在多个行业中的变革潜力。慢性病和感染疾病的日益增加以及全球人口老化,使得快速、精准的诊断解决方案需求巨大,而实验室晶片技术凭藉其小型化、便携性和经济高效的检测能力,提供了一种独特的解决方案。

医疗保健数位化和个人化医疗的趋势正在进一步推动市场成长,LOC设备能够实现精准的生物标记检测、基因分析和药物筛检,这些对于个人化治疗方案至关重要。此外,新兴经济体医疗费用支出的成长,以及政府为促进就地检验基础设施建设而采取的倡议,也创造了巨大的成长机会。

然而,微流控装置市场存在许多限制因素,包括高昂的初始研发成本、复杂的监管核准流程以及与装置标准化和生产扩充性相关的技术挑战。微流体装置的製造需要先进的专业技术和製造设施,这可能会限制中小企业进入市场,并阻碍其广泛应用。

此外,设备可靠性、交叉污染风险以及操作复杂系统需要熟练人员等问题可能会阻碍晶片实验室技术在资源匮乏地区的市场渗透。儘管有这些挑战,奈米技术的日益融合、人工智慧在增强数据分析方面的应用,以及在环境监测、食品安全检测和药物研发等领域的不断拓展,都带来了巨大的机会。预计这将推动实验室晶片市场的持续成长和技术进步。

本次调查的主要特点

  • 本报告对全球实验室晶片市场进行了详细分析,以 2024 年为基准年,给出了预测期(2025-2032 年)的市场规模(十亿美元)和復合年增长率(%)。
  • 它还重点介绍了各个细分市场的潜在商机,并说明了该市场具有吸引力的投资提案矩阵。
  • 该研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或核准、市场趋势、区域展望以及主要参与者采取的竞争策略的重要见解。
  • 本报告根据以下参数对全球实验室晶片市场的主要企业进行了分析:公司概况、产品系列、主要亮点、财务表现和策略。
  • 本报告的研究结果将使负责人和企业经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 这份全球实验室晶片市场报告的目标受众是该行业的各类相关人员,包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
  • 相关人员可以透过全球实验室晶片市场分析中使用的各种策略矩阵轻鬆做出决策。

目录

第一章 研究目标与前提条件

  • 调查目的
  • 先决条件
  • 简称

第二章 市场范围

  • 报告概述
    • 市场定义和范围
  • 执行摘要

第三章 市场动态、监理及趋势分析

  • 市场动态
  • 司机
  • 抑制因素
  • 机会
  • 影响分析
  • 重大进展
  • 法规环境
  • 产品上市及核准
  • PEST分析
  • 波特分析
  • 併购趋势
  • 产业趋势

4. 2020-2032年全球实验室晶片)

  • 试剂及耗材(晶片、试剂盒、微孔盘、检测试剂盒等)
  • 软体和服务(数据分析、远端监控、工作流程自动化等)
  • 装置及仪器(微流体晶片、感测器、致动器等)

5. 2020-2032年全球实验室晶片)

  • 微阵列
  • 微流体技术
  • 组织生物晶片
  • 其他(新兴或混合技术)

6. 2020-2032年全球实验室晶片市场(依应用领域划分)

  • 基因组学
  • 蛋白质体学
  • 诊断
  • 药物发现
  • 就地检验
  • 其他的

7. 2020-2032年全球实验室晶片)

  • 医院和诊所
  • 生物技术和製药公司
  • 诊断中心
  • 合约研究组织(CRO)
  • 法医学研究所
  • 居家医疗环境
  • 其他(学术和研究机构)

8. 2020-2032年全球实验室晶片市场(按地区划分)

  • 北美洲
    • 美国
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲国家
  • 欧洲
    • 德国
    • 英国
    • 西班牙
    • 法国
    • 义大利
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 韩国
    • ASEAN
    • 亚太其他地区
  • 中东
    • 海湾合作委员会国家
    • 以色列
    • 其他中东国家
  • 非洲
    • 南非
    • 北非
    • 中非

第九章 竞争情势

  • Abbott Laboratories
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Thermo Fisher Scientific
  • BioMerieux
  • Danaher Corporation
  • PerkinElmer
  • Illumina
  • QIAGEN
  • Merck Group
  • Roche Diagnostics
  • Becton Dickinson(BD)
  • Tecan Group
  • Luminex Corporation
  • Fluidigm Corporation

第十章 分析师建议

  • 机会
  • 分析师观点
  • Coherent Opportunity Map

第十一章 参考文献与调查方法

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI8825

Lab on Chip Market is estimated to be valued at USD 7.21 Bn in 2025 and is expected to reach USD 13.87 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.8% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 7.21 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.80% 2032 Value Projection: USD 13.87 Bn

The global lab on chip market represents a revolutionary convergence of microfluidics, biotechnology, and analytical chemistry, fundamentally transforming diagnostic and research methodologies across healthcare, pharmaceutical, and life sciences sectors.

Lab-on-chip (LOC) technology, also known as microfluidic devices, integrates multiple laboratory functions onto a single chip measuring just millimeters to a few centimeters in size, enabling miniaturized analysis of biological samples with unprecedented precision and efficiency. These sophisticated devices leverage microchannels, pumps, mixers, and detectors to perform complex biochemical processes including sample preparation, reaction, separation, and detection within a controlled microenvironment.

The technology's ability to reduce sample volumes, minimize reagent consumption, accelerate analysis time, and deliver high-throughput capabilities has positioned it as a cornerstone of modern point-of-care diagnostics and personalized medicine initiatives. As healthcare systems worldwide increasingly prioritize rapid, accurate, and cost-effective diagnostic solutions, particularly following the COVID-19 pandemic's emphasis on decentralized testing capabilities, lab-on-chip platforms have emerged as critical enablers of next-generation medical devices, supporting applications ranging from infectious disease detection and cancer biomarker analysis to environmental monitoring and drug discovery processes.

Market Dynamics

The global lab on chip market is propelled by several compelling drivers that underscore its transformative potential across multiple industries. The increasing prevalence of chronic diseases, infectious diseases, and the growing aging population worldwide creates substantial demand for rapid, accurate diagnostic solutions that lab-on-chip technology uniquely provides through its miniaturized, portable, and cost-effective testing capabilities.

Healthcare digitization trends and the shift toward personalized medicine further accelerate market growth, as LOC devices enable precise biomarker detection, genetic analysis, and drug screening applications essential for tailored therapeutic approaches. Additionally, rising healthcare expenditure in emerging economies, coupled with government initiatives promoting point-of-care testing infrastructure, creates significant market expansion opportunities.

However, the market faces notable restraints including high initial development costs, complex regulatory approval processes, and technical challenges related to device standardization and manufacturing scalability. The sophisticated nature of microfluidic device fabrication requires specialized expertise and advanced manufacturing facilities, potentially limiting market accessibility for smaller companies and creating barriers to widespread adoption.

Furthermore, concerns regarding device reliability, cross-contamination risks, and the need for skilled personnel to operate complex systems may hinder market penetration in resource-limited settings. Despite these challenges, substantial opportunities emerge from advancing nanotechnology integration, artificial intelligence incorporation for enhanced data analysis, and expanding applications in environmental monitoring, food safety testing, and pharmaceutical research, positioning the lab-on-chip market for sustained growth and technological evolution.

Key Features of the Study

  • This report provides in-depth analysis of the global lab on chip market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global lab on chip market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific, BioMerieux, Danaher Corporation, PerkinElmer, Illumina, QIAGEN, Merck Group, Roche Diagnostics, Becton Dickinson (BD), Tecan Group, Luminex Corporation, and Fluidigm Corporation
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global lab on chip market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lab on chip market

Market Segmentation

  • Product and Service Insights (Revenue, USD Bn, 2020 - 2032)
    • Reagents and Consumables (chips, cartridges, microplates, assay kits, etc.)
    • Software and Services (data analytics, remote monitoring, workflow automation, etc.)
    • Devices and Instruments (microfluidic chips, sensors, actuators, etc.)
  • Technology Insights (Revenue, USD Bn, 2020 - 2032)
    • Microarrays
    • DNA Microarrays (Gene Chips)
    • Protein Microarrays
    • Antibody Microarrays
    • Microfluidics
    • Continuous-flow Microfluidics
    • Droplet-based Microfluidics (Digital Microfluidics)
    • Optofluidics
    • Acoustofluidics
    • Tissue Biochip
    • 2D Cell Culture Chips
    • 3D Cell Culture and Organ-on-a-Chip
    • Others (emerging or hybrid technologies)
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Genomics
    • Proteomics
    • Diagnostics
    • Drug Discovery
    • Point-of-Care Testing
    • Others
  • End User Insights (Revenue, USD Bn, 2020 - 2032)
    • Hospitals and Clinics
    • Biotechnology and Pharmaceutical Companies
    • Diagnostic Centers
    • Contract Research Organizations (CROs)
    • Forensic Laboratories
    • Home Care Settings
    • Others (Academic and Research Institutes)
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott Laboratories
    • Agilent Technologies
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific
    • BioMerieux
    • Danaher Corporation
    • PerkinElmer
    • Illumina
    • QIAGEN
    • Merck Group
    • Roche Diagnostics
    • Becton Dickinson (BD)
    • Tecan Group
    • Luminex Corporation
    • Fluidigm Corporation

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Lab on Chip Market, By Product and Service
    • Global Lab on Chip Market, By Technology
    • Global Lab on Chip Market, By Application
    • Global Lab on Chip Market, By End User
    • Global Lab on Chip Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global Lab on Chip Market, By Product and Service, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Reagents and Consumables (chips, cartridges, microplates, assay kits, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Software and Services (data analytics, remote monitoring, workflow automation, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Devices and Instruments (microfluidic chips, sensors, actuators, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Lab on Chip Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Microarrays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • DNA Microarrays (Gene Chips)
      • Protein Microarrays
      • Antibody Microarrays
  • Microfluidics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • Continuous-flow Microfluidics
      • Droplet-based Microfluidics (Digital Microfluidics)
      • Optofluidics
      • Acoustofluidics
  • Tissue Biochip
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
      • 2D Cell Culture Chips
      • 3D Cell Culture and Organ-on-a-Chip
  • Others (emerging or hybrid technologies)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Lab on Chip Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Genomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Proteomics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Drug Discovery
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Point-of-Care Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Lab on Chip Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biotechnology and Pharmaceutical Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Diagnostic Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Forensic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Home Care Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others (Academic and Research Institutes)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Lab on Chip Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product and Service, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

9. Competitive Landscape

  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BioMerieux
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • PerkinElmer
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Illumina
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • QIAGEN
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Roche Diagnostics
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Becton Dickinson (BD)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Tecan Group
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Luminex Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Fluidigm Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us